Novo Nordisk’s success with the semaglutide-based drugs, Ozempic and Wegovy, has propelled Denmark’s economy and surpassed Tesla’s market cap, with key contributions from the India team.Novo’s Bengaluru team drives diabetes drug
Novo Nordisk’s success with the semaglutide-based drugs, Ozempic and Wegovy, has propelled Denmark’s economy and surpassed Tesla’s market cap, with key contributions from the India team.
